Skip to main content
Top
Published in: Trials 1/2014

Open Access 01-12-2014 | Study protocol

Effect of fluid and dietary sodium restriction in the management of patients with heart failure and preserved ejection fraction: study protocol for a randomized controlled trial

Authors: Karina SM d’Almeida, Eneida R Rabelo-Silva, Gabriela C Souza, Melina M Trojahn, Sofia LS Barilli, Jessica V Mansson, Andreia Biolo, Luis EP Rohde, Nadine Clausell, Luís Beck-da-Silva

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

Although half of all patients with heart failure (HF) have a normal or near-normal ejection fraction and their prognosis differs little from that of patients with a reduced ejection fraction, the pathophysiology of HF with preserved ejection fraction (HF-PEF) is still poorly understood, and its management poorly supported by clinical trials. Sodium and fluid restriction is the most common self-care measure prescribed to HF patients for management of congestive episodes. However, its role in the treatment of HF-PEF remains unclear. This trial seeks to compare the effects of a sodium- and fluid-restricted diet versus an unrestricted diet on weight loss, neurohormonal activation, and clinical stability in patients admitted for decompensated HF-PEF.

Methods/Design

This is a randomized, parallel trial with blinded outcome assessment. The sample will include adult patients (aged ≥18 years) with a diagnosis of HF-PEF admitted for HF decompensation. The patients will be randomized to receive a diet with sodium and fluid intake restricted to 0.8 g/day and 800 mL/day respectively (intervention group) or an unrestricted diet, with 4 g/day sodium and unlimited fluid intake (control group), and followed for 7 days or until hospital discharge. The primary outcome shall consist of weight loss at 7 days or discharge. The secondary outcome includes assessment of clinical stability, neurohormonal activation, daily perception of thirst and readmission rate at 30 days.

Discussion

Assessment of the effects of sodium and fluid restriction on neurohormonal activation and clinical course of HF-PEF can promote a deeper understanding of the pathophysiology and progression of this complex syndrome.

Trial registration number

ClinicalTrials.gov identifier: NCT01896908 (date of registration: 8 August 2013).
Appendix
Available only for authorised users
Literature
1.
go back to reference Oghlakian GO, Sipahi I, Fang JC: Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm?. Mayo Clin Proc. 2011, 86: 531-539. 10.4065/mcp.2010.0841.CrossRefPubMedPubMedCentral Oghlakian GO, Sipahi I, Fang JC: Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm?. Mayo Clin Proc. 2011, 86: 531-539. 10.4065/mcp.2010.0841.CrossRefPubMedPubMedCentral
2.
go back to reference Lam CS, Donal E, Kraigher-Krainer E, Vasan RS: Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011, 13: 18-28. 10.1093/eurjhf/hfq121.CrossRefPubMed Lam CS, Donal E, Kraigher-Krainer E, Vasan RS: Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011, 13: 18-28. 10.1093/eurjhf/hfq121.CrossRefPubMed
3.
go back to reference Hogg K, Swedberg K, McMurray J: Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004, 43: 317-327. 10.1016/j.jacc.2003.07.046.CrossRefPubMed Hogg K, Swedberg K, McMurray J: Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004, 43: 317-327. 10.1016/j.jacc.2003.07.046.CrossRefPubMed
4.
go back to reference Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, Marino EK, Lyles M, Cushman M, Enright PL, Cardiovascular Health Study Research Group: Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001, 87: 413-419. 10.1016/S0002-9149(00)01393-X.CrossRefPubMed Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, Marino EK, Lyles M, Cushman M, Enright PL, Cardiovascular Health Study Research Group: Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001, 87: 413-419. 10.1016/S0002-9149(00)01393-X.CrossRefPubMed
5.
go back to reference Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006, 355: 251-259. 10.1056/NEJMoa052256.CrossRefPubMed Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006, 355: 251-259. 10.1056/NEJMoa052256.CrossRefPubMed
6.
go back to reference Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006, 355: 260-269. 10.1056/NEJMoa051530.CrossRefPubMed Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006, 355: 260-269. 10.1056/NEJMoa051530.CrossRefPubMed
7.
go back to reference McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur Heart J. 2012, 14: 803-869.CrossRef McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur Heart J. 2012, 14: 803-869.CrossRef
8.
go back to reference Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999, 33: 1948-1955. 10.1016/S0735-1097(99)00118-7.CrossRefPubMed Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999, 33: 1948-1955. 10.1016/S0735-1097(99)00118-7.CrossRefPubMed
9.
go back to reference Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A, I-PRESERVE Investigators: Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008, 359: 2456-2467. 10.1056/NEJMoa0805450.CrossRefPubMed Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A, I-PRESERVE Investigators: Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008, 359: 2456-2467. 10.1056/NEJMoa0805450.CrossRefPubMed
10.
go back to reference Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J, PEP-CHF Investigators: The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006, 27: 2338-2345. 10.1093/eurheartj/ehl250.CrossRefPubMed Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J, PEP-CHF Investigators: The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006, 27: 2338-2345. 10.1093/eurheartj/ehl250.CrossRefPubMed
11.
go back to reference Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, CHARM Investigators and Committees: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003, 362: 777-781. 10.1016/S0140-6736(03)14285-7.CrossRefPubMed Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, CHARM Investigators and Committees: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003, 362: 777-781. 10.1016/S0140-6736(03)14285-7.CrossRefPubMed
12.
go back to reference Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KF, Gheorghiade M: Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation. 2006, 114: 397-403. 10.1161/CIRCULATIONAHA.106.628347.CrossRefPubMedPubMedCentral Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KF, Gheorghiade M: Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation. 2006, 114: 397-403. 10.1161/CIRCULATIONAHA.106.628347.CrossRefPubMedPubMedCentral
13.
go back to reference Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O’Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM, TOPCAT Investigators: Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014, 370: 1383-1392. 10.1056/NEJMoa1313731.CrossRefPubMed Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O’Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM, TOPCAT Investigators: Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014, 370: 1383-1392. 10.1056/NEJMoa1313731.CrossRefPubMed
14.
go back to reference Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Lohnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation, American Heart Associations Task Force on Practice Guidelines: 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013, 62: e147-e239. 10.1016/j.jacc.2013.05.019.CrossRefPubMed Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Lohnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation, American Heart Associations Task Force on Practice Guidelines: 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013, 62: e147-e239. 10.1016/j.jacc.2013.05.019.CrossRefPubMed
15.
go back to reference Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WHW, Teerlink JR, Walsh MN: Executive summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010, 16: 475-539. 10.1016/j.cardfail.2010.04.005.CrossRef Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WHW, Teerlink JR, Walsh MN: Executive summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010, 16: 475-539. 10.1016/j.cardfail.2010.04.005.CrossRef
16.
go back to reference Gupta D, Georgiopoulou VV, Kalogeropoulos AP, Dunbar SB, Reilly CM, Sands JM, Fonarow GC, Jessup M, Gheorghiade M, Yancy C, Butler J: Dietary sodium intake in heart failure. Circulation. 2012, 126: 479-485. 10.1161/CIRCULATIONAHA.111.062430.CrossRefPubMed Gupta D, Georgiopoulou VV, Kalogeropoulos AP, Dunbar SB, Reilly CM, Sands JM, Fonarow GC, Jessup M, Gheorghiade M, Yancy C, Butler J: Dietary sodium intake in heart failure. Circulation. 2012, 126: 479-485. 10.1161/CIRCULATIONAHA.111.062430.CrossRefPubMed
17.
go back to reference Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P: Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?. Clin Sci. 2008, 114: 221-230. 10.1042/CS20070193.CrossRefPubMed Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P: Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?. Clin Sci. 2008, 114: 221-230. 10.1042/CS20070193.CrossRefPubMed
18.
go back to reference Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P: Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol. 2009, 103: 93-102. 10.1016/j.amjcard.2008.08.043.CrossRefPubMed Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P: Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol. 2009, 103: 93-102. 10.1016/j.amjcard.2008.08.043.CrossRefPubMed
19.
go back to reference Parrinello G, Di Pasquale P, Licata G, Torres D, Giammanco M, Fasullo S, Mezzero M, Paterna S: Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure. J Card Fail. 2009, 15: 864-873. 10.1016/j.cardfail.2009.06.002.CrossRefPubMed Parrinello G, Di Pasquale P, Licata G, Torres D, Giammanco M, Fasullo S, Mezzero M, Paterna S: Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure. J Card Fail. 2009, 15: 864-873. 10.1016/j.cardfail.2009.06.002.CrossRefPubMed
20.
go back to reference Damgaard M, Norsk P, Gustafsson F, Kanters JK, Christensen NJ, Bie P, Friberg L, Gadsbøll N: Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol. 2006, 290: R1294-R1301.CrossRefPubMed Damgaard M, Norsk P, Gustafsson F, Kanters JK, Christensen NJ, Bie P, Friberg L, Gadsbøll N: Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol. 2006, 290: R1294-R1301.CrossRefPubMed
21.
go back to reference Volpe M, Magri P, Rao MA, Cangianiello S, DeNicola L, Mele AF, Memoli B, Enea I, Rubattu S, Gigante B, Trimarco B, Epstein M, Condorelli M: Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition. Hypertension. 1997, 30: 168-176. 10.1161/01.HYP.30.2.168.CrossRefPubMed Volpe M, Magri P, Rao MA, Cangianiello S, DeNicola L, Mele AF, Memoli B, Enea I, Rubattu S, Gigante B, Trimarco B, Epstein M, Condorelli M: Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition. Hypertension. 1997, 30: 168-176. 10.1161/01.HYP.30.2.168.CrossRefPubMed
22.
go back to reference Volpe M, Tritto C, DeLuca N, Rubattu S, Rao MA, Lamenza F, Mirante A, Enea I, Rendina V, Mele AF: Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation. 1993, 88: 1620-1627. 10.1161/01.CIR.88.4.1620.CrossRefPubMed Volpe M, Tritto C, DeLuca N, Rubattu S, Rao MA, Lamenza F, Mirante A, Enea I, Rendina V, Mele AF: Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation. 1993, 88: 1620-1627. 10.1161/01.CIR.88.4.1620.CrossRefPubMed
23.
go back to reference Arcand J, Ivanov J, Sasson A, Floras V, Al-Hesayen A, Azevedo ER, Mak S, Akkard JP, Newton GE: A high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study. Am J Clin Nutr. 2011, 93: 332-337. 10.3945/ajcn.110.000174.CrossRefPubMed Arcand J, Ivanov J, Sasson A, Floras V, Al-Hesayen A, Azevedo ER, Mak S, Akkard JP, Newton GE: A high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study. Am J Clin Nutr. 2011, 93: 332-337. 10.3945/ajcn.110.000174.CrossRefPubMed
24.
go back to reference Lennie TA, Song EK, Wu JR, Chung ML, Dunbar SB, Pressler SJ, Moser DK: Three gram sodium intake is associated with longer event-free survival only in patients with advanced heart failure. J Card Fail. 2011, 17: 325-330. 10.1016/j.cardfail.2010.11.008.CrossRefPubMedPubMedCentral Lennie TA, Song EK, Wu JR, Chung ML, Dunbar SB, Pressler SJ, Moser DK: Three gram sodium intake is associated with longer event-free survival only in patients with advanced heart failure. J Card Fail. 2011, 17: 325-330. 10.1016/j.cardfail.2010.11.008.CrossRefPubMedPubMedCentral
25.
go back to reference Aliti GB, Rabelo ER, Clausell N, Rohde LE, Biolo A, Beck-da-Silva L: Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial. JAMA Intern Med. 2013, 173: 1058-1064. 10.1001/jamainternmed.2013.552.CrossRefPubMed Aliti GB, Rabelo ER, Clausell N, Rohde LE, Biolo A, Beck-da-Silva L: Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial. JAMA Intern Med. 2013, 173: 1058-1064. 10.1001/jamainternmed.2013.552.CrossRefPubMed
26.
go back to reference Hummel SL, Seymour EM, Brook RD, Kolias TJ, Sheth SS, Rosenblum HR, Wells JM, Weder AB: Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction. Hypertension. 2012, 60: 1200-1206. 10.1161/HYPERTENSIONAHA.112.202705.CrossRefPubMedPubMedCentral Hummel SL, Seymour EM, Brook RD, Kolias TJ, Sheth SS, Rosenblum HR, Wells JM, Weder AB: Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction. Hypertension. 2012, 60: 1200-1206. 10.1161/HYPERTENSIONAHA.112.202705.CrossRefPubMedPubMedCentral
27.
go back to reference Cardoso JN, Ochiai ME, Oliveira MT, Reis CM, Curiati M, Vieira KR, Barreto AC: Diuretic titration based on weight change in decompensated congestive heart failure: a randomized trial. Int J Cardiol. 2013, 168: 3020-3021. 10.1016/j.ijcard.2013.04.023.CrossRefPubMed Cardoso JN, Ochiai ME, Oliveira MT, Reis CM, Curiati M, Vieira KR, Barreto AC: Diuretic titration based on weight change in decompensated congestive heart failure: a randomized trial. Int J Cardiol. 2013, 168: 3020-3021. 10.1016/j.ijcard.2013.04.023.CrossRefPubMed
28.
go back to reference Sauer J, Rabelo ER, Castro RA, Goldraich L, Rohde LE, Clausell N, Beck-da-Silva L: Nurses’ performance in classifying heart failure patients based on physical exam: comparison with cardiologist’s physical exam and levels of N-terminal pro-B-type natriuretic peptide. J Clin Nurs. 2010, 19: 3381-3389. 10.1111/j.1365-2702.2010.03403.x.CrossRefPubMed Sauer J, Rabelo ER, Castro RA, Goldraich L, Rohde LE, Clausell N, Beck-da-Silva L: Nurses’ performance in classifying heart failure patients based on physical exam: comparison with cardiologist’s physical exam and levels of N-terminal pro-B-type natriuretic peptide. J Clin Nurs. 2010, 19: 3381-3389. 10.1111/j.1365-2702.2010.03403.x.CrossRefPubMed
29.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470. 10.7326/0003-4819-130-6-199903160-00002.CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470. 10.7326/0003-4819-130-6-199903160-00002.CrossRefPubMed
Metadata
Title
Effect of fluid and dietary sodium restriction in the management of patients with heart failure and preserved ejection fraction: study protocol for a randomized controlled trial
Authors
Karina SM d’Almeida
Eneida R Rabelo-Silva
Gabriela C Souza
Melina M Trojahn
Sofia LS Barilli
Jessica V Mansson
Andreia Biolo
Luis EP Rohde
Nadine Clausell
Luís Beck-da-Silva
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-347

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue